Structure Therapeutics Inc.
GPCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,428 | $1,497 | $951 | $951 |
| - Cash | $170 | $130 | $26 | $0 |
| + Debt | $4 | $5 | $0 | $1 |
| Enterprise Value | $1,262 | $1,373 | $925 | $952 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$157 | -$102 | -$52 | -$38 |
| % Margin | – | – | – | – |
| Net Income | -$123 | -$90 | -$51 | -$40 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.34 | -2.43 | -1.44 | -1.2 |
| % Growth | 3.7% | -68.8% | -20% | – |
| Operating Cash Flow | -$117 | -$79 | -$46 | -$32 |
| Capital Expenditures | -$1 | -$2 | -$0 | -$1 |
| Free Cash Flow | -$118 | -$82 | -$46 | -$33 |